Abstract: Thyroid cancer is an increasingly common cancer. Despite its excellent prognosis, there is marked variation in thyroid cancer management with many patients at risk for overtreatment. Understanding the complexity of treatment decision making is key to minimizing overtreatment and improving thyroid cancer care.
Center for Bioethics and Social Sciences in MedicineThe Complexity of Treatment Decision Making in Low-Risk Thyroid Cancer
CBSSM Seminar: with Megan R. Haymart, MD, Associate Professor of Medicine Division of Metabolism, Endocrinology, & Diabetes & Hematology/Oncology
April 30, 2019
3:00 pm - 4:00 pm
NCRC, Building 16, 266C
Sponsored by: Center for Bioethics and Social Sciences in Medicine
Contact Information: Kerry Ryan kryanz@umich.edu
Abstract: Thyroid cancer is an increasingly common cancer. Despite its excellent prognosis, there is marked variation in thyroid cancer management with many patients at risk for overtreatment. Understanding the complexity of treatment decision making is key to minimizing overtreatment and improving thyroid cancer care.